# Xenon Pharmaceuticals Inc.: Form 8-K, filed Nov 27, 2023

- Company: [Xenon Pharmaceuticals Inc.](/companies/xene.md) (CIK 1582313)
- Form: 8-K
- Filed: 2023-11-27
- Accepted by EDGAR: Nov 27, 2023, 12:03 ET
- Period: 2023-11-27
- Accession: 0000950170-23-066032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1582313/000095017023066032/xene-20231127.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1582313/000095017023066032/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1582313/000095017023066032/xene-20231127.htm

Filed Nov 27, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-066032. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.